Pharmaceutical giant Pfizer Inc. announced on July 10 that it will roll back price increases on dozens of drugs that went into effect on July 1.
“Following an extensive discussion with President Trump today, Pfizer’s Chairman and CEO Ian Read announced that it will defer the company’s price increases that were effective on July 1 to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access for patients,” the company said in a statement.
